公开(公告)号：US20220290073A1

公开(公告)日：2022-09-15

申请号：US17691263

申请日：2022-03-10

申请人： Bausch + Lomb Ireland Limited

发明人： Vicki Barniak ,  Catherine Scheuer ,  William T. Reindel ,  John Michael Duex ,  Andrea E. Giallombardo ,  Elora Supersad

IPC分类号： C11D3/00 ,  C11D3/22 ,  C11D3/04 ,  C11D3/20 ,  C11D1/66 ,  A61K9/00

摘要： A preservative-free contact lens treating solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the preservative-free contact lens treating solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the preservative-free contact lens treating solution, of erythritol; (c) one or more nonionic surfactants; (d) sodium chloride, potassium chloride or any combination thereof; and (e) one or more buffers.

公开(公告)号：US20220288107A1

公开(公告)日：2022-09-15

申请号：US17691265

申请日：2022-03-10

申请人： Bausch + Lomb Ireland Limited

发明人： Vicki Barniak ,  Catherine Scheuer ,  William T. Reindel ,  John Michael Duex ,  Andrea E. Giallombardo

IPC分类号： A61K31/728 ,  A61K47/02 ,  A61K47/26 ,  A61K47/10 ,  A61K9/00 ,  A61P27/04

摘要： An ophthalmically compatible solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the ophthalmically compatible solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the ophthalmically compatible solution, of erythritol; (c) sodium chloride, potassium chloride or any combination thereof; and (d) one or more buffers.

公开(公告)号：US12097295B2

公开(公告)日：2024-09-24

申请号：US17398556

申请日：2021-08-10

申请人： Bausch + Lomb Ireland Limited

发明人： Vicki Barniak ,  Catherine Scheuer ,  Ruth Julian ,  William T. Reindel ,  Erning Xia

IPC分类号： A61L12/14 ,  B65B55/06 ,  B65B55/22

CPC分类号： A61L12/147 ,  B65B55/06 ,  B65B55/22

摘要： A packaging system for the storage of an ophthalmic device is disclosed. The packaging system comprises a sealed container containing one or more unused ophthalmic devices immersed in an aqueous packaging solution comprising (a) one or more osmoprotectants, (b) one or more poloxamer comfort agents and (c) one or more polyol demulcents, wherein the aqueous packaging solution has an osmolality of at least about 150 mOsm/kg, a pH of about 6 to about 9 and is heat sterilized.

公开(公告)号：US20240189342A1

公开(公告)日：2024-06-13

申请号：US18584219

申请日：2024-02-22

申请人： Bausch + Lomb Ireland Limited

发明人： Vicki Barniak ,  Catherine Scheuer ,  William T. Reindel ,  John Michael Duex ,  Andrea E. Siverling

IPC分类号： A61K31/728 ,  A01N33/12 ,  A01N37/52 ,  A01P1/00 ,  A61K9/00 ,  A61K47/02 ,  A61K47/10 ,  A61K47/26 ,  A61L12/14 ,  A61P27/04 ,  C11D1/66 ,  C11D1/722 ,  C11D3/00 ,  C11D3/04 ,  C11D3/20 ,  C11D3/22 ,  C11D3/48

CPC分类号： A61K31/728 ,  A01N33/12 ,  A01N37/52 ,  A01P1/00 ,  A61K9/0048 ,  A61K47/02 ,  A61K47/10 ,  A61K47/26 ,  A61L12/142 ,  A61L12/145 ,  A61P27/04 ,  C11D1/66 ,  C11D1/722 ,  C11D3/0078 ,  C11D3/046 ,  C11D3/2065 ,  C11D3/222 ,  C11D3/227 ,  C11D3/48

摘要： An ophthalmically compatible solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the ophthalmically compatible solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the ophthalmically compatible solution, of erythritol; (c) sodium chloride, potassium chloride or any combination thereof; and (d) one or more buffers.

公开(公告)号：US11944638B2

公开(公告)日：2024-04-02

申请号：US17691265

申请日：2022-03-10

申请人： Bausch + Lomb Ireland Limited

发明人： Vicki Barniak ,  Catherine Scheuer ,  William T. Reindel ,  John Michael Duex ,  Andrea E. Siverling

IPC分类号： A61K31/728 ,  A01N33/12 ,  A01N37/52 ,  A01P1/00 ,  A61K9/00 ,  A61K47/02 ,  A61K47/10 ,  A61K47/26 ,  A61L12/14 ,  A61P27/04 ,  C11D1/66 ,  C11D1/722 ,  C11D3/00 ,  C11D3/04 ,  C11D3/20 ,  C11D3/22 ,  C11D3/48

CPC分类号： A61K31/728 ,  A01N33/12 ,  A01N37/52 ,  A01P1/00 ,  A61K9/0048 ,  A61K47/02 ,  A61K47/10 ,  A61K47/26 ,  A61L12/142 ,  A61L12/145 ,  A61P27/04 ,  C11D1/66 ,  C11D1/722 ,  C11D3/0078 ,  C11D3/046 ,  C11D3/2065 ,  C11D3/222 ,  C11D3/227 ,  C11D3/48

摘要： An ophthalmically compatible solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the ophthalmically compatible solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the ophthalmically compatible solution, of erythritol; (c) sodium chloride, potassium chloride or any combination thereof; and (d) one or more buffers.

公开(公告)号：US20220290072A1

公开(公告)日：2022-09-15

申请号：US17691260

申请日：2022-03-10

申请人： Bausch + Lomb Ireland Limited

发明人： Vicki Barniak ,  Catherine Scheuer ,  William T. Reindel ,  John Michael Duex ,  Andrea E. Giallombardo

IPC分类号： C11D3/00 ,  A01N33/12 ,  A01N37/52 ,  A01P1/00 ,  C11D1/722 ,  C11D3/22 ,  C11D3/20 ,  C11D3/04 ,  C11D3/48 ,  A61L12/14

摘要： A contact lens treating solution includes (a) about 0.005 to about 2 wt. %, based on the total weight of the contact lens treating solution, of hyaluronic acid or a salt thereof; (b) about 0.01 to about 1 wt. %, based on the total weight of the contact lens treating solution, of erythritol; (c) one or more nonionic surfactants; (d) sodium chloride, potassium chloride or any combination thereof; and (e) one or more buffers.